p-methyl-2-methoxyphenyl p-toluenesulfonate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: p-methyl-2-methoxyphenyl p-toluenesulfonate
• 英文别名: 2-Methoxy-4-methylphenyl 4-toluenesulfonate；(2-methoxy-4-methylphenyl) 4-methylbenzenesulfonate
• 化学式: C₁₅H₁₆O₄S
• 分子量: 292.356
• InChiKey: ATQQVVZYXFJTQF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  61
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  甲苯-4-磺酸4-甲酰基-2-甲氧基-苯基酯 在 palladium 10% on activated carbon 、 氢气 作用下， 以 乙酸乙酯 为溶剂， 20.0 ℃ 、101.33 kPa 条件下， 反应 40.0h， 以53%的产率得到p-methyl-2-methoxyphenyl p-toluenesulfonate
  参考文献：
  名称：

  A Mild and Selective Method for the Catalytic Hydrodeoxygenation of Cyanurate Activated Phenols in Multiphasic Continuous Flow

  摘要：

  sA low-energy, high-selectivity approach to the catalytic hydrodeoxygenation of phenols is reported using batch or continuous flow methods to react 3 equiv of phenol with cyanuric chloride then hydrogenolyzing the triarylcyanurate intermediate to give 3 equiv of deoxo aromatic. The use of cyanuric chloride compares favorably with existing activation methods, showing improved scalability, atom efficiency, and economics. The scope of both the activation and hydrogenolysis stages are explored using lignin-related phenols. Initial development has identified that continuous stir tank reactors (CSTRs) enable a multiphasic process for converting guaiacol to anisole and at steady state overcome the catalyst deactivation issues observed in batch, seemingly caused by the cyanurate byproduct. Green chemistry aspects and the potential for industrial adoption are discussed.

  DOI：

  10.1021/acs.oprd.6b00314

文献信息

• PHARMACEUTICAL COMPOSITION COMPRISING PYRAZOLONE DERIVATIVE
  申请人：Genecare Research Institute Co., Ltd

  公开号：EP1900728A1

  公开（公告）日：2008-03-19

  The present invention relates to pharmaceutical compositions containing a compound represented by formula (I), or a pharmaceutically acceptable prodrug or salt thereof, or a hydrate or solvate thereof as an active ingredient, (wherein, R1, R2, R3, and R4 are the same as R1, R2, R3, and R4 in the description of the present invention).

  本发明涉及含有由式(I)所代表的化合物、其药用可接受的前药或盐、或其水合物或溶剂和作为活性成分的药物组合物（其中，R1、R2、R3和R4与本发明描述中的R1、R2、R3和R4相同）。
• PYRAZOLONE DERIVATIVE
  申请人：Genecare Research Institute Co., Ltd

  公开号：EP1905762A1

  公开（公告）日：2008-04-02

  The present invention relates to compounds represented by formula (I), or pharmaceutically acceptable prodrugs or salts thereof, or hydrates or solvates thereof, (wherein, R1, R2, R3, and R4 are the same as R1, R2, R3, and R4 in the description of the present invention).

  本发明涉及由式(I)表示的化合物，其药学上可接受的前药或盐，或其水合物或溶剂化物，其中，R1、R2、R3和R4与本发明说明中的R1、R2、R3和R4相同。
• A Mild and Selective Method for the Catalytic Hydrodeoxygenation of Cyanurate Activated Phenols in Multiphasic Continuous Flow
  作者：Yuhan Zhao、Georgina King、Maria H.T. Kwan、A. John Blacker

  DOI：10.1021/acs.oprd.6b00314

  日期：2016.11.18

  sA low-energy, high-selectivity approach to the catalytic hydrodeoxygenation of phenols is reported using batch or continuous flow methods to react 3 equiv of phenol with cyanuric chloride then hydrogenolyzing the triarylcyanurate intermediate to give 3 equiv of deoxo aromatic. The use of cyanuric chloride compares favorably with existing activation methods, showing improved scalability, atom efficiency, and economics. The scope of both the activation and hydrogenolysis stages are explored using lignin-related phenols. Initial development has identified that continuous stir tank reactors (CSTRs) enable a multiphasic process for converting guaiacol to anisole and at steady state overcome the catalyst deactivation issues observed in batch, seemingly caused by the cyanurate byproduct. Green chemistry aspects and the potential for industrial adoption are discussed.